SE0302775D0 - Chemical compound and assay - Google Patents

Chemical compound and assay

Info

Publication number
SE0302775D0
SE0302775D0 SE0302775A SE0302775A SE0302775D0 SE 0302775 D0 SE0302775 D0 SE 0302775D0 SE 0302775 A SE0302775 A SE 0302775A SE 0302775 A SE0302775 A SE 0302775A SE 0302775 D0 SE0302775 D0 SE 0302775D0
Authority
SE
Sweden
Prior art keywords
assay
chemical compound
erg
ligand compound
compounds
Prior art date
Application number
SE0302775A
Other languages
English (en)
Swedish (sv)
Inventor
Gert Strandlund
Brian Springthorpe
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302775A priority Critical patent/SE0302775D0/xx
Publication of SE0302775D0 publication Critical patent/SE0302775D0/xx
Priority to TW093130894A priority patent/TW200526255A/zh
Priority to PCT/SE2004/001499 priority patent/WO2005037052A2/en
Priority to AT04793802T priority patent/ATE399322T1/de
Priority to EP04793802A priority patent/EP1678499B1/de
Priority to DE602004014633T priority patent/DE602004014633D1/de
Priority to JP2006536480A priority patent/JP2007513874A/ja
Priority to US10/575,523 priority patent/US20070048215A1/en
Priority to ES04793802T priority patent/ES2307058T3/es
Priority to CNA2004800307531A priority patent/CN1871516A/zh
Priority to HK06109478A priority patent/HK1089233A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
SE0302775A 2003-10-20 2003-10-20 Chemical compound and assay SE0302775D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0302775A SE0302775D0 (sv) 2003-10-20 2003-10-20 Chemical compound and assay
TW093130894A TW200526255A (en) 2003-10-20 2004-10-12 Chemical compound and assay
CNA2004800307531A CN1871516A (zh) 2003-10-20 2004-10-18 利用标记的桥合二哌啶的结合测试方法
EP04793802A EP1678499B1 (de) 2003-10-20 2004-10-18 Chemische verbindung und test
AT04793802T ATE399322T1 (de) 2003-10-20 2004-10-18 Chemische verbindung und test
PCT/SE2004/001499 WO2005037052A2 (en) 2003-10-20 2004-10-18 Binding assay with labelled bispidine variant
DE602004014633T DE602004014633D1 (de) 2003-10-20 2004-10-18 Chemische verbindung und test
JP2006536480A JP2007513874A (ja) 2003-10-20 2004-10-18 標識ビスピジン異形での結合アッセイ
US10/575,523 US20070048215A1 (en) 2003-10-20 2004-10-18 Chemical compound and assay
ES04793802T ES2307058T3 (es) 2003-10-20 2004-10-18 Compuesto quimico y ensayo.
HK06109478A HK1089233A1 (en) 2003-10-20 2006-08-25 Chemical compound and assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302775A SE0302775D0 (sv) 2003-10-20 2003-10-20 Chemical compound and assay

Publications (1)

Publication Number Publication Date
SE0302775D0 true SE0302775D0 (sv) 2003-10-20

Family

ID=29546593

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302775A SE0302775D0 (sv) 2003-10-20 2003-10-20 Chemical compound and assay

Country Status (11)

Country Link
US (1) US20070048215A1 (de)
EP (1) EP1678499B1 (de)
JP (1) JP2007513874A (de)
CN (1) CN1871516A (de)
AT (1) ATE399322T1 (de)
DE (1) DE602004014633D1 (de)
ES (1) ES2307058T3 (de)
HK (1) HK1089233A1 (de)
SE (1) SE0302775D0 (de)
TW (1) TW200526255A (de)
WO (1) WO2005037052A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080037655A (ko) 2005-07-21 2008-04-30 아스트라제네카 아베 신규 피페리딘 유도체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
DE3730224A1 (de) * 1987-09-09 1989-03-23 Kali Chemie Pharma Gmbh 3-cinnamyl-3,7-diazabicyclo(3,3,1) nonan-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
AR030302A1 (es) * 2000-07-07 2003-08-20 Astrazeneca Ab Compuestos de bispidina, formulacion farmaceutica, uso para la fabricacion de medicamentos, proceso para la preparacion de estos compuestos y compuestos intermediarios
AU2001277863A1 (en) * 2000-07-14 2002-01-30 Merck And Co., Inc. Radioligand and binding assay
DK1410019T3 (da) * 2001-07-13 2006-03-06 Janssen Pharmaceutica Nv Assay for kardiovaskulær sikkerhed
EP1423700A2 (de) * 2001-09-04 2004-06-02 Pfizer Limited Affinitätsassay für den humanen erg kaliumkanal

Also Published As

Publication number Publication date
EP1678499A2 (de) 2006-07-12
EP1678499B1 (de) 2008-06-25
JP2007513874A (ja) 2007-05-31
ATE399322T1 (de) 2008-07-15
CN1871516A (zh) 2006-11-29
WO2005037052A3 (en) 2005-07-07
ES2307058T3 (es) 2008-11-16
US20070048215A1 (en) 2007-03-01
TW200526255A (en) 2005-08-16
HK1089233A1 (en) 2006-11-24
WO2005037052A2 (en) 2005-04-28
DE602004014633D1 (de) 2008-08-07

Similar Documents

Publication Publication Date Title
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
ATE306553T1 (de) Verwendung von hydroxylphenyl pyruvate dioxygenase ( hppd ) inhibitoren als selektionsmittel für pflanzentransformation
DE502005002227D1 (de) Lanthanoidchelate und ihre anwendung in der bioanalytik
EA200200530A1 (ru) Гетероциклические замещенные пиразолоны
ATE386814T1 (de) Gemischte g-proteinzusammensetzung und ihre verwendung
WO2004070352A3 (en) Methods, mixtures, kits and compositions pertaining to analyte determination
EA200801063A1 (ru) Диароматические амины
ATE424560T1 (de) Marker für neuromyelitis optica
HK1092841A1 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and /or diabetes
EA200301100A1 (ru) Новые фталазиноны
ATE439869T1 (de) Automatisches radioaktives markierungsverafhren
DE60322019D1 (de) Kaliumkanal-modulatoren
BR0317229A (pt) Composição e uso de agonista completo de alfa7nachr
MXPA04001730A (es) Metodo para determinacion de multiples analitos.
ATE308046T1 (de) Kardiovaskulares sicherheitstestverfahren
WO2005000875A3 (en) Compositions and methods comprising a ligand of chemerin receptor
ATE221657T1 (de) Entstörung durch rheumafaktoren
HK1089233A1 (en) Chemical compound and assay
EA200500125A1 (ru) СПОСОБ ОБОГАЩЕНИЯ И ОБНАРУЖЕНИЯ ПАТОЛОГИЧЕСКИ ИЗМЕНЕННЫХ ПРИОНПРОТЕИНОВ (PrP)
AU2003247802A8 (en) Method for chemiluminescent detection
PT941975E (pt) Cimento para injeccao contendo inibidores de corrosao
EA200401211A1 (ru) Применение углеводородной композиции в качестве маркера и способ детектирования маркера в углеводородной композиции
EA200001034A1 (ru) Способ ингибирования mrp1
ATE366260T1 (de) Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen.
WO2004078783A3 (en) Enzymes involved in apoptosis